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1. Introduction 
Lethal Dose 50 is a quantity derived statistically, in order 
to declare a single dose of something expected 
compound can be deadly or cause significant toxic 
effects in 50% of experimental animals after treatment. 
LD50 is a quantitative benchmark that is often used to 
express the lethal dose range (Loomis, 1978). 
Toxic effects on living creatures can be seen and can not. 
When the absorbed dose is relatively small, the damage 
can be limited to a few cells only. There are still quite a 
lot of healthy cells to keep normal function of organs. If 
the cells were damaged, then the organ can no longer 
function normally. At that time usually poisoning (toxic 
work) appeared, generally as a disease process that is 
integral to the individual (Koeman, 1987). 
The main objective of acute toxicity test of a drug or 
chemical is to establish the potential for acute toxicity, 
the dose range lethal or toxic dose related drugs, at one 
or more test animals. Moreover, this test is also intended 
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to assess various clinical symptoms arise, the toxic 
effects of typical and intermediary mechanisms deaths 
of test animals. The initial criteria are often used to 
evaluate the toxicity testing of new compounds 
commonly used as an index to estimate mortality lethal 
dose that may occur in humans. The LD50 alue is the 
amount of the dose of a compound that can cause death 
in 50% of the population in a given period of time 
(Loomis, 1978). 
Pediocin N6 powder including class IIa bacteriocin which 
is resistant to heat, produced from isolates of 
Pediococcus pentosaceus strain N6 and has high 
antimicrobial activity mainly against pathogenic bacteria 
Listeria monocytogenes. One of the requirements for the 
application of an antimicrobial peptide as food 
preservative would be the evaluation of its 
immunogenicity and Also the in vitro and in vivo toxicity. 
The testing of a potential antimicrobial food would 
Consider repeated and daily administration of the 
substance for a required time period to access a possible 
chronic toxicity (Pariza and Foster, 1983 and Pariza and 
Cook, 2010). The route of administration should be the 
same proposed for use in humans (Food and Drug 
Administration, 1988 and Post, 1996) and toxicological 
studies involving animals are a major component of 
safety assessment of bacteriocins (Moreno et al., 2000). 
Pediocin N6 powders have the potential to be used as a 
natural preservative in food. According to Tagg et al. 
(1976), bacteriocins as food biopreservatif must meet 
criteria such as preservatives or food additives among 
other more secure for consumers, has a bactericidal 
activity against the Gram-positive and Gram negative, 
stable, evenly distributed in the food system and 
economical. Therefore it is necessary for toxicity tests to 
determine the toxicity of the Pediocin N6 powder 
through a test dose of a toxic or lethal dose (LD50) in test 
animals male white mice. 
 
2. Materials and Methods 
2.1. Material 
Male white mice Swiss types 2- 3 months old as 
much as 20 fish weighing 20 to 25 grams,  feed pellets 
white mice and Pediocin N6 powder. 
 
2.2. Giving a Dose of Pediocin N6 Powder Solution 
Pediocin N6 powder produced from isolates 
Pediococcus pentosaceus strain N6 pure. Production of 
Pediocin N6 powder capsule do with the material as 
much as 20% consists of maltodextrin and skim milk at a 
ratio of 5: 1 (83.3%: 16.67%) according to the methods 
Kailasapathy (2002) and the Pediocin N6 powder in it as 
much as 20%. The dose of Pediocin N6 powder solution 
according to the method Loomis (1987), appropriate 
treatment dose divided mice body weight plus 5 ml of 
water. A treatment consisting of 5000 mg / kg, 10,000 
mg /kg, 15,000 mg /kg and 20,000 mg /kg, then 
reconstituted with 5 mL of water. For the treatment of 
5000 mg /kg means Pediocin N6 powder given as 125 mg 
then added 5 ml of water and so on appropriate 
treatment dose. Award solution Pediocin N6 powder 
done every morning during treatment. Before 
administering solution Pediocin N6 powder, mice were 
fasted for 4 hours before treatment but still were given a 
drink and 2 hours after treatment. 
 
2.3. Granting Volume Solution Award Pediocin N66 
Powder 
Pediocin N6 powder solution according to the 
methods Kailasapathy (2002), given according to the 
weight of mice treated mice divided heaviest weight 
multiplied by  1 ml. Award solution Pediocin N6 powder 
done orally. Treated mice based on weight, volume 
solution of Pediocin N6 powder given as much as 0.8 g 
/ml, 0.84 g /ml, 0.88 g /ml, 0.92 g /ml, 0.96 g /ml and 1 g 
/ml. 
 
2.4. Acute Toxity 
Acute toxicity was assessed with 20 male mice and 
Pediocin N6 powder solution was administered orally at 
a dose according to treatment by Loomis (1987). After 
administration, the animals were kept under observation 
for a minimum of 48 h. The number of animals killed for 
each of the doses was Noted and the LD50 calculated by 
the Up and Down method, the which is one of the most 
used to reduce the number of animals used (Botham, 
2004). In this study tested the dose of Pediocin N6 
powder lowest 5.000 mg /kg and the highest dose is 
20,000 mg /kg. 
 
2.5. Experimental Animals 
Swiss type male mice as many as 20 birds were used for 
the experiments. Mice used were weighing between 20 
and 25 g were Provided and kept in plastic boxes with 
food and water ad libitum. The animals were used in 
experiments after a period of 7 days of adaptation in 
captivity, with regular 12 h light-dark periods and an 
ambient temperature of 20°C (National Institutes of 
Health, 1996). The procedures used in the assays were 
approved by the Internal Committee of Animal Ethics-
UFSM (protocol number 68/2010), and conform to 
international standards of animal welfare, as specified by 
the CIOMS International Guiding Principles for 
Biomedical Research Involving Animals, Geneva, 1985. 
Pediocin N6 powder solution was administered orally as 
prescribed treatment, for 15 days of treatment. The 
feeding is done 2 times a day ie morning and evenings as 
much as 5 g /head/day. Mice were fasted meal 4 hours 
before treatment but still were given a drink and 2 hours 
after treatment. Weighing mice conducted 2 days for 15 
days of treatment. Observed number of deaths of test 
animals for 24 hours after treatment and continued 
observation is followed up to 15 days. Number of dead 
white mice data processed by the method of Reed and 
Muench. 
 
2.6. Calculation of LD50 
The number of dead mice was calculated by LD50. 
LD50 data were analyzed by the method of Reed and 
Muench (1938) is by calculating the proportion of the 
distance is then determined logarithm dose comparison. 
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LD50 is determined by adding the log dose is low and the 
product of the distance proportion ratio higher dose to 
the lowest dose. 
The equation to obtain LD50 namely: 
g = h x i, y = g + log s, LD50 = anti log y 
Where : 
h: pole 
A: The percentage of deaths smaller and closest of the 
50% 
b: a larger percentage of deaths and the closest of the 
50% 
i:  Increase dosage 
k: The dose that causes the death of the larger and 
most close to 50% 
s: The dose that causes the death of smaller and 
closest of the 50% 
g: The result of multiplying the increase in dose to the 
size of the distance 
y: The result of the addition between g and logs 
 
2.7. Preference test 
 The method used is non factorial design in 
completely randomized design consists of 4 treatments 
and 5 replications. The test animals were divided into 4 
groups and each treatment consisted of 5 mice. The 
treatments were tested in accordance Loomis (1978), 
consisting of: 
1. Powder bacteriocins as much as 5000mg/kg 
body weight of mice. 
2. Powder bacteriocins as much as 10,000mg/kg 
body weight of mice. 
3. Powder bacteriocins 15,000 mg/kg body weight 
of mice. 
4. Powder bacteriocins as much as 20,000 mg/kg 
body weight of mice. 
 
Table 1. The Number of Deaths Mice During Treatment 
Dosis 
(mg/kg BB) 
Deaths Mice the  
Sum 
The Life Mice 
 
5000 0 5 
10.000 0 5 
15.000 0 5 
20.000        0                                5 
LD50 Calculation of, g = h x i , y = g + log s , LD50 =  log y 
Against 
Point Based on up: h = 50%-a,    i = log k 
             b- a        s 
h = 50% - 0 = 0     i = 0, g = h x i= 0 
            0 
y = g + log s = 0, LD50= log y Against, LD50   = log 0 Against 
= 0 
 
Measured Variables 
Changes in body weight of mice every two days 
after a single dose of oral solution Pediocin N6 powder. 
 
3. Results and Discussion 
The number of deaths of test animals during 15 
days of treatment is oral administration of a single dose 
of Pediocin N6 powder solution of can be seen in Table 1. 
The results of the above study showed that giving a 
solution of Pediocin N6 powder until a dose of 20,000 
mg / kg administration of a single oral dose in mice did 
not reveal any mortality up to 15 days of treatment. 
Based on the LD50 value of a single oral dose can not be 
calculated, based on the results of this study can only be 
expressed LD50 value pseudo Pediocin N6 powder 
greater than 20,000 mg/kg in male mice. Based on these 
tests show that the Pediocin N6 powder not toxic for 
white mice. This means Pediocin N6 powder safe used as 
biopreservatif in food because it comes from isolates of 
Lactic Acid Bacteria (LAB) Pediococcus pentosaceus strain 
N6. According Alakomi et al. (2000), this bacterium 
include microorganisms GRAS (Generally Recognized As 
Safe) or group of microorganisms that safely be added in 
food because it is not toxic so it is known as Good Grade 
Microorganisms are microorganisms that are not a 
health risk. Furthermore, according to Barefoot and 
Klaeuhammer (1983), bacteriocins are antimicrobial 
compounds easily degraded by proteolytic enzymes in 
the digestive systems of humans and animals. 
Bacteriocins produced by lactic acid bacteria is very 
advantageous in the food industry, especially in the 
fermented food product as the activity could inhibit the 
growth of some bacteria contaminants cause decay and 
diseases are transmitted through food (food borne 
illnes). The addition of bacteriocins in foods other than 
to prevent spoilage as well as to extend the storage time 
of food and inhibits the growth of pathogenic bacteria. 
According Jeevaratnam et al. 2005, the pickling 
process food combined with heating in industrial 
processes and reduce the number of pathogenic 
microbes in this process involves microbes. Microbial 
resistance in industrial processes is a problem, and 
therefore in need of food preservation modern 
technology with a stable microbial warming and improve 
the quality of the food. Preserving biological microbes 
involves assistance in the form of BAL. LAB produce 
lactic acid component causing pathogenic bacteria are 
not able to grow more food. BAL utilization as a 
preservative is indispensable because it has antibacterial 
activity and resistance to heat. 
According Bhunia et al. (1990) evaluated the 
immunogenicity of pediocin PA-1 (ACh) to mice and 
found that it was not immunogenic for animals. Short-
term administration of diets containing nisin (Nisaplin) 
induced an increase of of both CD4 and CD8 T-
lymphocyte cell counts and Also a Decrease of B-
lymphocyte counts. The macrophage / monocyte 
fraction was isolated from peripheral blood Became 
Significantly Increased after long-term administration 
(100 days) of Nisaplin-containing diets (De Pablo et al., 
1999). 
 Although Several antimicrobial peptides have been 
purified and Characterized there are currently few 
studies on acute toxicity for comparison. Extensive 
toxicological studies Showed that nisin intake does not 
cause toxic effects to the human body with a Reported 
LD50 of 6950 mg / kg, the which is similar to salt, when 
Administered Orally (Jozala et al., 2007). Pediocin PA-1 is 
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another bacteriocin that has been used for the same 
purpose, and studies on its toxicity have been Reported 
(Bhunia et al., 1990 and Dabour et al., 2009), Although its 
use was not yet recommended by WHO (Drider et al., 
2006). Some authors have associated high LD50 of 
bacteriocins with digestive enzymes capable of Rapidly 
inactivating Reviews These substances, being trypsin 
and chymotrypsin produced in the pancreas and 
released into the small intestine a prime example (Hara 
et al., 1962, Eckner, 1992 and Cleveland et al ., 2001, 
Deegan et al., 2006). In this regard, the peptide P34 is 
sensitive to trypsin as well (Motta et al., 2007a). Claypool 
et al. (1966) evaluated the effect of nisin in milk 
chocolate consumed Orally and Noted that only ¼ of the 
original concentration was detected in saliva after a 
minute of use. Besides this, some bacteriocins can also 
be sometimes sensitive to ptyalin, being not detected in 
human saliva 10 min after the consumption of a liquid 
containing bacteriocin (Chandrapati and O'Sullivan, 
1998).  
 
 
 
Figure 1. Graph Effect of Single Dose Oral Solution Pediocin N6 Powder Mice Against Weight Changes During Treatment 
 
Developmental changes in body weight of male 
mice for 15 days treatment of a single dose of an oral 
solution of Pediocin N6 powders can be seen in Figure 
1.The results of the analysis of changes in body weight of 
mice to a single dose of an oral solution of Pediocin N6 
powder on white mice provide a significantly different 
effect to increase body weight in mice between the 13th 
day of treatment, the dose of 15,000 mg/Kg BW 
(H13D15.000 mg/Kg BW) with other treatments. Based 
on the results of treatment rataannya H13D15.000 mg/kg 
resulted in changes in body weight were higher at 30.2 
grams. The use of solution Pediocin N6 powder to 
20,000 mg /kg also showed changes in weight gain in 
mice. This shows that the administration of a solution of 
Pediocin N6 powder until a dose of 20,000 mg /kg did 
not cause toxic or poisonous to the rats on the contrary 
increase the body weight of mice. This is because the 
solution Pediocin N6 powder is a protein that is safe to 
eat mice can even be used as a source of protein for the 
body of mice and promote weight loss. According to 
Tagg et al. (1976), bacteriocins is a protein compound 
(such as peptides) that is bactericidal against microbes 
(bacteria) that if the terms of filogeniknya have close 
relations with the bacteriocin-producing microbes. 
According to Salminen et al. (2004), bacteriocins is a 
protein or peptide compounds that can didgradasi by 
protease enzymes in the digestive tract of humans and 
animals. This causes the bacteriocins can be used as an 
antimicrobial agent that is safe to preserve food. 
Additionally bacteriocins can inhibit bacterial spoilage 
and pathogenic bacteria in food. 
Pediocin N6 powder dosing 15,000 mg /kg on day 1 
until day - 12 happens to weight gain in mice but not 
statistically significant influence. Changes in body weight 
of mice to give real effect to raise the weight of mice on 
day 13 and then decreased at day -15. Dosing bacteriocins 
15,000 mg /kg give real effect to increase body weight in 
mice as bacteriocins are proteins that can be used by the 
body in mice as a source of protein for weight gain in 
mice. According Savadogo et al. (2006), Bacteriocins a 
protein molecule or peptide ekstrasellular which have 
bactericidal or bacteriostatic action against bacteria that 
have a close kinship. The bacteriocins can be degraded 
by proteases in the digestive tract. Bacteriocins are 
irrevesibel, easy to digest, positive effect on health and 
active at low concentrations. 
Treatment dosing Pediocin N6 powder to 20,000 
mg/kg (H15D20.000 mg/Kg BW) influence changes in 
weight were not significantly different from other 
Pediocin N6 powder treatment, this suggests that the 
intake of nutrients derived from mice to growth-
treatment the same treatment. The average weight gain 
in mice at a dose of treatment Pediocin N6 powder 
20,000 mg/kg every 2 days weighing from day 1 to day 15 
of treatment of 2.1 gr. Means there is weight gain of 1 
g/head/day, corresponding according to Smith and 
Mangkoewidjojo (1988), that the normal range of the 
United Nations in mice by 1 g/ head /day. This is because 
the nutritional content of this treatment according to 
the needs of mice than that of male mice is more 
efficient in the use of feed. 
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4. Conclusion 
The results of toxicity testing solution on the 
Pediocin N6 powder white male mice showed that 
solution Pediocin N6 powder. Until a dose 20.000 mg /kg 
in a single oral dose administration did not reveal any 
mortality up to 15 days of treatment. Based on the LD50 
value of a single oral dose can not be calculated, based 
on it can be stated LD50 value pseudo Pediocin N6 
powder greater than 20,000 mg /kg in mice. This caused 
Pediocin N6 powder solution is a protein that can be 
degraded by proteolytic enzymes in the digestive 
channel  animals and humans that are safe for 
consumption. The average changes in body weight of 
mice at a dose treatment solution Pediocin N6 powder 
to 20,000 mg /kg every 2 days weighing from day 1 to 
day 15 of 2.1 gr. Based on these tests Pediocin N6 
powder safe used as indstri biopreservatif on meat and 
food processing involves heating. 
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